More evidence that the promotion of Remdesivir has more to do with money than efficacy:

"National Yang Ming Chiao Tung University researchers have identified four antiviral drug candidates that can inhibit SARS-CoV-2, which causes COVID-19, the team leader said on Tuesday.

One of the drug candidates — JMY206 — is more than 10 times stronger than remdesivir, the first antiviral drug fully certified for the treatment of COVID-19, said Yang Jinn-moon (楊進木), dean of the university’s College of Biological Science and Technology.

The other drugs identified are boceprevir, an oral, direct-acting hepatitis C virus protease inhibitor; telaprevir, a hepatitis C drug; and nelfinavir, an antiretroviral drug used to treat HIV-positive patients."

Seems there are a bunch of drugs equal to or better than Remdesivir - so why is it the only one given approval?

This is reminiscent of the 2001 anthrax terror attack where Cipro became the 'Drug of the Day' despite several other antibiotics being equally effective.